U.S. Markets closed
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • Dow 30

    34,935.47
    -149.06 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.59 (-0.71%)
     
  • Russell 2000

    2,226.25
    -13.78 (-0.62%)
     
  • Crude Oil

    73.81
    +0.19 (+0.26%)
     
  • Gold

    1,816.90
    -18.90 (-1.03%)
     
  • Silver

    25.55
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1872
    -0.0024 (-0.2018%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • Vix

    18.24
    +0.54 (+3.05%)
     
  • GBP/USD

    1.3908
    -0.0050 (-0.3547%)
     
  • USD/JPY

    109.6500
    +0.1890 (+0.1727%)
     
  • BTC-USD

    41,501.60
    +41.68 (+0.10%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Global PCR and Realtime PCR Testing Market Forecast to Decline at a CAGR of -10.93% from 2020 to reach $12,546.83 Million in 2025 - ResearchAndMarkets.com

·4 min read

DUBLIN, July 22, 2021--(BUSINESS WIRE)--The "PCR and Realtime PCR Testing Global Market Opportunities and Strategies to 2030: COVID-19 Implication and Growth" report has been added to ResearchAndMarkets.com's offering.

The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market reached a value of nearly $22,380 million in 2020, having increasing at a compound annual growth rate (CAGR) of 28.11% since 2015. The growth is mainly due to the increase in demand for these tests due to the pandemic.

The market is expected to decline at a CAGR of -10.93% from 2020 to reach $12,546.83 million in 2025. The global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market is expected to stabilize and reach $17,054.69 million in 2030, at a CAGR of 6.33%.

North America was the largest region in the global polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market, accounting for 34.5% of the total in 2020. It was followed by Asia Pacific, Western Europe, and then the other regions. Going forward, the fastest-growing regions in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market will be South America and Eastern Europe, where growth will be at CAGRs of -8.2% and -8.5% respectively. These will be followed by the Africa, and Middle East where the markets are expected to grow at CAGRs of -8.6% and -9.1% respectively, during 2019-2025.

The top opportunities in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market segmented by product will arise in the instruments segment, which will decline by $1,623.4 million of global annual sales by 2025. The top opportunities in the polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market segmented by end-user will arise in the industrial application end-user segment, which will decline by $872.5 million of global annual sales by 2025. The polymerase chain reaction (PCR) and real-time polymerase chain reaction (PCR) testing market size will decline the least in Indonesia at $85.8 million.

Scope of the report:

Markets Covered:

1) By Product: Consumables & Reagents; Instruments; Software

2) By End-Users: Clinical Diagnostics; Life Science Research; Industrial Applications; Others

Companies Mentioned: Agilent Technologies, Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific, Inc.; bioMerieux SA; Bio-Rad Laboratories, Inc.

Metrics Covered: Number of Enterprises; Number of Employees

Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; UK; Germany; France; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, PCR and realtime PCR testing indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Companies Mentioned

  • Agilent Technologies, Inc.

  • F. Hoffmann-La Roche AG

  • Thermo Fisher Scientific, Inc.

  • bioMerieux SA

  • Bio-Rad Laboratories, Inc.

  • Abbott Laboratories

  • General Electric Company

  • Danaher Corporation

  • Becton Dickinson And Company

  • Luminex Corporation

  • NuHigh Biotechnologies Co. Ltd

  • Beijing Applied Biological Technologies Co. Ltd.

  • Dirui Industrial Co., Ltd.

  • Fapon Biotech Inc.

  • Heal Force Bio-meditech Holdings Limited

  • Integrated BioSystems Co. Ltd.

  • Jiangsu Bioperfectus Technologies Co., Ltd.

  • Roche Diagnostics India Pvt Ltd

  • Abbott India Limited

  • Qiagen India Pvt Ltd

  • bioMerieux India

  • Becton Dickinson Private Limited

  • Biocartis

  • Bio-Techne India Private Limited

  • Kaneka Corporation

  • F. Hoffmann-La Roche AG

  • Siemens Healthineers AG

  • Qiagen N.V.

  • Biocartis Group NV

  • bioMerieux SA

  • QuantuMDx

  • Interlabservis

  • GeneMe

  • Siemens Healthineers Ukraine

  • TestLine Clinical Diagnostics s.r.o.

  • Agilent Technologies Inc.

  • Qiagen

  • Bio-Rad Laboratories Inc.

  • Sysmex Inostics

  • Abbott

  • Thermo Fischer Scientific Inc.

  • Eppendorf AG

  • Seimens healthcare

  • Beckmen Coulter Inc.

  • Cepheid

  • Clontech Laboratories

  • Eppendorf

  • Fluidigm

  • PerkinElmer

  • Harvard Bioscience

  • Maxim Biotech

  • Promega

  • Kapa Biosystems

  • Rain Dance technologies

  • GE Healthcare

  • Draegerwerk AG

  • B. Braun Melsungen

  • ResMed Inc.

  • Smiths Medical

For more information about this report visit https://www.researchandmarkets.com/r/kk0ejr

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005474/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900